While it may seem that inhaled insulin is the answer for noncompliant or needle-fearing diabetics, if the drug is even approved, some patients may still be required to keep their needles. Exubera is the inhaled version of a type of insulin taken after meals, but many diabetics require baseline insulin, which is longer-acting and still only available by injection.
FDA Panel Backs Inhaled Insulin
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts